Lido Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $562K | Buy |
|
|||||
|
2025
Q2 | $530K | Sell |
|
|||||
|
2025
Q1 | $597K | Sell |
|
|||||
|
2024
Q4 | $515K | Buy |
|
|||||
|
2024
Q3 | $438K | Buy |
|
|||||
|
2024
Q2 | $228K | Buy |
|
|||||
|
2024
Q1 | $233K | Sell |
|
|||||
|
2023
Q4 | $260K | Buy |
|
|||||
|
2023
Q3 | $131K | Sell |
|
|||||
|
2023
Q2 | $465K | Sell |
|
|||||
|
2023
Q1 | $763K | Buy |
|
|||||
|
2022
Q4 | $231K | Sell |
|
|||||
|
2022
Q3 | $230K | Sell |
|
|||||
|
2022
Q2 | $130K | Sell |
|
|||||
|
2022
Q1 | $288K | Buy |
|
|||||
|
2021
Q4 | $211K | Sell |
|
|||||
|
2021
Q3 | $374K | Buy |
|
|||||
|
2021
Q2 | $215K | Sell |
|
|||||
|
2021
Q1 | $255K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $58K | Sell |
|
|||||
|
2020
Q2 | $121K | Sell |
|
|||||
|
2020
Q1 | $104K | Sell |
|
|||||
|
2019
Q4 | $106K | Sell |
|
|||||
|
2019
Q3 | $156K | Sell |
|
|||||
|
2019
Q2 | $331K | Sell |
|
|||||
|
2019
Q1 | $644K | Buy |
|
|||||
|
2018
Q4 | $217K | Buy |
|
|||||
|
2018
Q3 | $378K | Buy |
|
|||||
|
2018
Q2 | $273K | Buy |
|
|||||
|
2018
Q1 | $142K | Buy |
|